New pills to combat obesity are threatening Eli Lilly and Novo Nordisk on the stock market. The two pharmaceutical companies are the dominant players in the weight loss market, since (for the time being) they are the only ones producing and marketing anti-obesity drugs. However, this is a very greedy business and in recent months other laboratories, attracted by this millionaire empire, have made progress with their own drugs, arousing the interest of the market and sparking doubts about the empire of the two giants, which have seen shares fall.
New anti-obesity pills threaten Eli Lilly and Novo Nordisk’s stock market empire
hace 2 meses
19
Relacionado
Tendencias
Popular
Bus universitario de Nariño con 21 ocupantes se vuelca en el...
hace 18 horas
3
En Envigado, una mujer que fue atacada con un machete logró ...
hace 23 horas
2
Tres presuntos extorsionistas de comerciantes de Robledo fue...
hace 22 horas
2
Cristiano sigue haciendo goles con Portugal, que brilla en l...
hace 22 horas
2
[Video] ¿No lo vio? Camión atropelló a vehículo particular a...
hace 21 horas
2
© Desde Aqui Medellin 2024. Todos los derechos reservados